Cyclophilin J (CYPJ) is an important tumor suppressor that restricts LUBAC-mediated NF-κB activation by impeding the interaction between HOIP and SHARPIN, thereby inhibiting the proliferation and migration of human CRC cells [128]. This evidence concerns the gene NFKB1 and neoplasm.